Background: Mendelian randomization (MR) has provided major opportunities for understanding the causal relationship among complex traits. Previous studies have often evaluated MR methods based on simulations that do not adequately reflect the data-generating mechanism in GWAS and there are often discrepancies in performance of MR methods in simulations and real datasets.
Introduction
Epidemiological associations are often biased by unobserved confounders. Mendelian randomization (MR) -a form of instrumental variable approach that uses genetic variants as instruments -has provided major opportunities for understanding the causal relationship across complex traits [1] [2] [3] . The validity of early MR methods relied on a crucial assumption that the genetic variants have no effects on the outcome that are not mediated by the exposure. This assumption can be violated in the presence of "horizontal pleiotropy". Recent studies have found that pleiotropy is a wide-spread phenomenon [4] [5] [6] [7] [8] [9] , leading to concerns over the accuracy of Mendelian randomization analysis. To deal with this challenge, many methods have been proposed that take advantage of the multitude of genetic instruments to reduce the bias due to horizontal pleiotropy. Different methods deal with different kinds of pleiotropy and often rely on different assumptions [7, [10] [11] [12] [13] [14] .
Choosing a method for MR analysis can be challenging. While a number of previous studies have conducted various simulation studies to evaluate MR methods under alternative modeling assumptions, conclusions may be limited because these studies often do not incorporate realistic model for genetic architecture of complex traits as implied by recent studies of heritability/co-heritability [4, [15] [16] [17] [18] [19] and effect-size distribution [20] [21] [22] [23] . Further, many simulation studies also directly simulate data on the instruments ignoring the process that instruments in reality are selected to be SNPs that reach genome-wide significance in an underlying genome-wide association study -as a result of which there should be a close relationship between sample size, number of available instruments, their average effect-sizes and precision of their estimated effects. Previous MR studies have used a fixed number of IVs and a fixed sample size [7, 14, 24] or vary one of them without the other [10-12, 25, 26] , and generate the effects of genetic instruments from a fixed distribution without varying with the sample size or the number of IVs. In addition, genetic effects on exposure and outcomes are often simulated using uniform distributions while clearly many studies have shown they more likely to follow a spike-and-slab type distributions [22, 23, 27] . The magnitude of genetic effects simulated is also unrealistic in some studies such as only 25 SNPs explaining as much as 94% of variance of the exposure [10] or selected IVs explaining larger variance of the outcome than the exposure [28] . Because of these issues, performance of MR methods, in absolute and relative terms, can be discrepant between simulation studies and real GWAS datasets.
In this paper, we use a simulation framework that closely mirror real genome-wide association studies. In particular, we simulate data on genome-wide set of SNPs and select instruments based on SNPs which reach genome-wide significance in the underlying study of the exposure.
We simulate genetic effects constrained by realistic values for heritability/co-heritability and models for effect-size distribution [4, [15] [16] [17] [18] [19] [20] [21] [22] [23] . We compare performance of a variety of existing methods under different sample sizes of underlying GWAS and correspondingly number of IVs and vary the proportion of valid instruments and mechanisms of pleiotropy. We further compare the methods in real data analysis to estimate the effect of blood and urine biomarkers on type 2 diabetes. Results from these simulation studies provide comprehensive and realistic insights into strengths and limitations of existing methods.
Methods
We begin by introducing a few notations. Let denote the exposure, denote the outcome and denote a potential confounder. Let % denote the genotype of SNP . Throughout most MR literature [10-12, 26, 28] , the simulations are conducted using the following model Here % , % , % denote the direct effect of SNP on , and , respectively. We also adopt this model in our simulations. But unlike most previous studies that simulate only the selected instruments, we generate data for all common variants in the genome. We are interested in estimating the causal effect ( ) of on . The effects of the confounder on and are denoted by .5 and .9 , respectively. The error terms . , 6 and : are independent and normally distributed with mean 0.
We generated data from model (1) Table 1 and Supplementary Table 1 for details on values used for the parameters).
Balanced Horizontal Pleiotropy with InSIDE Assumption violated
Next we allow the InSIDE assumption to be violated by allowing a fraction of SNPs to have an effect on the confounder . Here we generate % , % , % from the tri-variate normal mixture: In the above, the first component corresponds to valid instruments which have only direct effect on . The second component allows a set of SNPs that have effects on and thus creating horizontal pleiotropic effect with the InSIDE assumption violated. We also allow the same set of SNPs to have direct effects on and , but the effect sizes are of smaller magnitude.
Directional Pleiotropy
In the above two settings, we assumed direct effects of the SNPs on the outcome have mean zero. Next to simulate directional pleiotropy, we generate % from a distribution with non-zero mean ( 9 ). When the InSIDE assumption holds, we simulate from ( 4)
Simulating Data on Genome-wide Association Studies
We simulate individual level data for independent genome-wide association studies for and following the above model when sample size is not too large ( ≤ 100 ). However, for very large sample size, generation and analysis of individual level data can become computationally prohibitive and we simulate summary-level association statistics directly (addressed as summary-level simulations). We observe that the total effects of SNPs on and are implied by model (1)-(3):
Thus, we simulate % , % and % s as before and then directly generate summary statistics by adding to %5 and %9 error terms with mean 0 and variance inversely proportional to the sample size. Details can be found in the Supplementary Note 1.
Choosing Parameters Values Reflecting Realistic Genetic Architecture
We found previous studies for evaluation of MR methods have often not followed realistic model for genetic architecture of complex traits. In particular, a very recent study that evaluated a large number of methods for MR analysis following the basic setup described in (1)-(3), used highly unrealistic parameter settings [28] . The study assumes the instruments explain an unrealistically large proportion of the variance of and and ignore the relationship between sample size, number of instruments and effect-size distributions ( Supplementary Table 2 , Supplementary Note 2).
We chose parameter values in our model so that they reflect realistic genetic architecture of complex traits and results from our simulated GWAS track what are typically observed in empirical studies. In Table 1 , we show the parameter values chosen for different simulation settings and corresponding values of heritability of the two traits and their co-heritability due to horizontal and vertical pleiotropy. Further in Figure 1 , we show how under simulation settings as the sample size for GWAS of increases, the number of available IVs and the amount of variance they explain for the two traits increase. These patterns closely correspond to that observed in GWAS of many traits, such as BMI. Further see Supplementary Table 1 for the exact choice of parameters.
( Table 1 here)
Existing Robust MR Methods
We compare all nine methods investigated in the recent study indicated above [28] , which include weighted median [11] , weighted mode [12] , MR-Egger [10] , MR-Robust, MR-Lasso [25] , MR-RAPS [29] , MR-PRESSO [7] , MRMix [13] and contamination mixture (Con-mix) [14] .
In addition, we include the inverse-variance weighted method with multiplicative random effects (IVW-r) in comparison [30] . See Supplementary Note 3 for a summary of the different methods and Supplementary Table 3 for the software and tuning parameters used to implement the methods.
MR Analysis for Biomarker effects on Type 2 diabetes
We applied the variety of available methods for MR analysis to investigate causal effect of 38 blood and urine biomarker measures in the UK Biobank study [31] on the risk of type-2 diabetes (T2D). We accessed the summary statistics from recent analysis of the biomarkers in the UK Biobank (N=318 984) [31] . We restricted the analysis to those biomarkers which have more than 25 associated instruments and the instruments explain at least 1% of the biomarker variance. On the outcome side, we accessed summary statistics from the largest GWAS on type 2 diabetes which consists of 74 124 T2D cases and 824 006 controls [32] . Details are included in Supplementary Note 4.
Results
We present main results under the simulation scheme that generate summary-level data directly as it allows exploration of GWAS of very large sample size ( > 100 ). Under smaller sample size where we did simulation with both individual and summary-level data, we see the results are very comparable across the two schemes (see Supplementary Figures 1 and 2) .
Under balanced pleiotropy and InSIDE assumption, the weighted mode estimator and MRMix controls type I error at the nominal level across different scenarios (Figure 2) Figure 3) .
We also compared the different methods in terms of bias and variance separately. Under balanced pleiotropy and InSIDE assumptions, all MR methods generally show some bias when the sample size is small and gradually the bias diminishes as the sample size increases (Supplementary Figure 4) . When there is no causal effect, all methods give average estimates of causal effect close to 0 across wide range of sample sizes except for Egger regression with ≤ 100 and Con-mix with = 1000 and large number of invalid IVs. Comparing the empirical versus estimated standard errors of the methods we observe that the MR-Lasso and Con-mix produce severely underestimated standard errors (Supplementary Figure 5) , while weighted median and MR-PRESSO has underestimated standard error when 70% of the instruments are valid. This is likely to be the reason for type I error inflation. Throughout the settings IVW-r, MR-Egger, MR-Robust and MR-RAPS give accurate standard error estimation;
weighted mode has overestimated standard error which is likely to be the reason for its overly conservative type I error rate. The standard error estimate of MRMix tends to be too large when ≤ 100 , but converges to the truth when ≥ 200 .
When the InSIDE assumption is violated, we find all methods except weighted mode and MRMix could have extremely inflated type I error (Figure 4) . and had substantially higher power than weighted mode, which also controls the type I error (Supplementary Figure 6) . When we inspected bias and variance separately, it is evident that when the InSIDE assumption is violated all methods, except weighted mode and MRMix, can have large bias, even when there is no causal effect, and this bias does not disappear with increasing sample size (Supplementary Figure 7) . The patterns of bias in standard error estimation for the different methods are similar as what we described before when the InSIDE assumption is satisfied (Supplementary Figure 8) .
In the simulations with directional pleiotropy, the patterns are fairly similar with corresponding scenarios for balanced pleiotropy setting except that the type I error for a number of methods increased somewhat in certain settings (Supplementary Figures 9-14) .
Causal effects of biomarkers on type 2 diabetes
We further compared the methods in real data analysis to estimate the causal effects of 38 UK Biobank blood and urine biomarkers on type 2 diabetes. We focus on those 19 biomarkers which were found reported to have significant causal effect at < 0.005 by at least one of the methods.
Unsurprisingly, all the methods consistently report that higher levels of glucose causally increase the risk of T2D (Figure 6 and Supplementary Figure 15 ). Another T2D biomarker,
HbA1C, also has a substantial causal effect on T2D consistently across all the methods. Interestingly, these biomarkers generally have small to moderate effects on T2D. The results appear to be less homogeneous for the biomarkers that are shown to have a substantial effect on T2D (|log ( )| > 0.25) by some methods (Figure 6 and Supplementary Figure 15 ). triglycerides. Similar patterns were also observed for glucose, HbA1C and ALT, which were discussed previously.
We also observed that the estimated confidence interval (CI) by Con-mix and MR-Lasso tend to be substantially smaller than those by the other methods. In a number of cases, e.g. total bilirubin and urate, Con-mix report confidence intervals of similar or smaller length to that by the fixed-effect IVW (IVW-fe). These results are consistent with simulation studies which indicated that the CI estimates by these two methods can be anti-conservative and can lead to type I error.
Discussion
In this paper, we evaluate a variety of methods for polygenic MR analysis using a simulation framework which generate data closely resembling patterns observed in empirical genome-wide association studies. Results reveal varying performance of the MR methods under different scenarios. When the sample size is large (e.g. 5 > 200 , 9 > 100 ), MRMix appears to be best or close to be best, whether or not InSIDE assumption is satisfied, in terms of its ability to control type I error rate and bias and yet maintaining relatively high power and low MSE. When the sample size is smaller (e.g. 5 ≤ 100 , 9 ≤ 50 ) , no method appears to be performing uniformly well across all scenarios. When the InSIDE assumption holds, IVW-r, MR-Robust and MR-RAPS lead to the smallest mean-squared errors and they usually have either well controlled or modestly inflated type I error rates. The weighted median method also performs well when the proportion of valid IVs is not too high (e.g. ≤ 30%) but suffers from more severe type I error when this proportion increases. When the InSIDE assumption is violated, only weighted mode and MRMix have well controlled type I error and all the other methods can have severely inflation in type I error. Between these two methods, weighted mode tends to be more efficient and powerful for moderate sample size (e.g. 5 ≤ 80 , 9 ≤ 40 ) .
We observe that the type I error of a number of methods are significantly affected due to not only bias in point estimation but also that of the underlying standard error estimators. In particular, we found that the type I error of the weighted mode can often be substantially lower than the desired nominal level due to conservativeness of underlying standard error estimator ( Supplementary Figure 5 and 8) . Further for a number of other estimators, which did not have bias in point estimation at least when the InSIDE assumption is satisfied, have inflated type I error due to anticonservative standard error estimation. It is possible that in the future the type I error or/and power for some of these procedures can be improved through implementation of more robust standard error estimation procedures.
Both similarities and differences exist between our simulation results and the results reported in a recent study also comparing most of the same MR methods [28] . Both studies found that the weighted mode estimator has well controlled type I error rate across various scenarios. The biggest difference is observed for mixture model based methods. In our study, MRMix is shown to perform well under large sample size, especially when the InSIDE assumption is violated.
The study by Slob and Burgess restricted their simulation studies with sample size 5 = 9 = 10 000. Under such small sample size, MRMix can be unstable because the performance of the method depends on the ability of the underlying mixture model to cluster valid and invalid IVs based on underlying variance components. If the sample size is small and estimates of effect sizes for the IVs have large variability, then the two variance components are not well separable and the resulting estimates can have large uncertainty. When sample size increases, variance component associated with valid IVs are expected to be smaller than those with the non-valid IVs and then the method allows robust estimation of causal effects. In addition, we find the alternative mixture model-based method, Con-mix can have smaller MSE than that of MRMix specially for smaller sample sizes, but the former method can have much higher type I error across a variety of scenarios with or without the InSIDE assumption violated. We also observed a numerical breakdown of Con-mix for very large GWAS (e.g 5 = 1000 ) for which the cause is not well understood.
The simulation framework we propose can be broadly useful for future evaluation of emerging MR methods. We simulate data on genome-wide panel of SNPs and apply a p-value threshold to select IVs as is done in real studies. This procedure naturally reflects the relationship among sample size, number of IVs and instrument strength. We also use realistic distributions to generate genetic effect sizes based on recent work on heritability and effect size distributions [4, [15] [16] [17] [18] [19] [20] [21] [22] [23] . We studied the performance of MR methods in a wide range of sample sizes and scenarios of violations of standard assumptions of MR analysis. We propose a framework for directly simulating summary-level data implied by the model for individual data for reducing the computational burden associated with simulating vary large GWAS.
Results from simulation studies and real data analysis were generally consistent. The number of instruments available for the different biomarkers and the associated variances explained were within reasonable range of scenarios considered in the simulation studies given the sample size. Both simulation studies and real data analysis show that IVW-r, MR-PRESSO, MR-Robust, MR-Lasso and MR-RAPS tend to give similar estimates of causal effects, while the estimates from weighted mode, MRMix and Con-mix are close to each other. Both simulation studies and real data analysis also indicated the estimated confidence intervals of MR-Lasso and Con-mix can be anti-conservative and thus lead to increased type-I error. (Supplementary Figures 5   and 8, Figure 6) .
In summary, we conducted large-scale and realistic simulation studies to compare 10 methods for Mendelian randomization analysis. Our results show that while for GWAS with very large size the mixture model based method MRMix emerges as the most robust method, for medium to smaller sample sized studies there is no single method that performs uniformly well across all scenarios. Thus in real data analysis it is prudent to apply a few alternative methods with complimentary features and strengths and assess sensitivity of findings across all these methods.
Code availability
The code for the simulation studies is available on GitHub:
https://github.com/gqi/MR_comparison_simulations . MR estimates and corresponding 95% confidence intervals of causal effects from UK Biobank blood and urine biomarkers to type 2 diabetes. MR estimate is the log-OR of type 2 diabetes (T2D) per SD increase in the exposure. We present the results for biomarkers that satisfy three criteria: 1) >25 IVs 2) IVs explain >1% variance of the exposure 3) have a causal effect on T2D at & < 0.005 by at least one method (except IVW-fe). IVW-fe: IVW with fixed effects; IVW-r: IVW with random effects. Title of each panel is the name of the biomarker followed by number of IVs. 
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